ReShape Lifesciences Inc. (OTCMKTS:RSLSD – Get Free Report)’s share price traded up 2.3% during mid-day trading on Monday . The company traded as high as $5.37 and last traded at $5.37. 6,500 shares were traded during trading, an increase of 377% from the average session volume of 1,362 shares. The stock had previously closed at $5.25.
ReShape Lifesciences Trading Up 2.3 %
The company has a current ratio of 1.17, a quick ratio of 1.07 and a debt-to-equity ratio of 0.05. The company has a 50-day moving average price of $5.37.
About ReShape Lifesciences
ReShape Lifesciences Inc, a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy.
See Also
- Five stocks we like better than ReShape Lifesciences
- The Significance of Brokerage Rankings in Stock Selection
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- What Investors Need to Know to Beat the Market
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for ReShape Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReShape Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.
